Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FHY8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,676
Award facts
- Contract value 100% obligated
- $19,675.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 5, 2025, for Zepbound 12.5 mg/0.5 mL pen injections valued at $19,675.68. This firm fixed-price delivery order is non-competitive and carries an ultimate completion date of November 6, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Zepbound is a semaglutide-based medication indicated for chronic weight management, reflecting the DLA's procurement of specialized pharmaceutical therapeutics for beneficiaries within the military healthcare system, including service members, retirees, and their families. The delivery order will be fulfilled from AmerisourceBergen's distribution operations in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution infrastructure. This award demonstrates the company's continued role as a critical vendor for federal medical procurement and its capability to deliver specialized pharmaceutical products efficiently under the DLA's centralized medical supply chain framework.
Quick answers
Who was awarded contract SPE2DR26FHY8M?
SPE2DR26FHY8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FHY8M worth?
The government has obligated $19,676 on SPE2DR26FHY8M.
Is contract SPE2DR26FHY8M an order under another contract?
Yes. SPE2DR26FHY8M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY8M competed?
The extent of competition for SPE2DR26FHY8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award